Countdown to Ethereum Pectra Upgrade Activation: Learn more
$2.59T
Total marketcap
$266.96B
Total volume
BTC 60.43%     ETH 7.27%
Dominance

CTLT Stock

63.48 {{ price }} 0.000000% {{change_pct}}%
Exchange
NYSE
Market Cap
0
LOW - HIGH [24H]
0.0000 - 0.0000
VOLUME [24H]
0
{{ volume }}
P/E Ratio
0
Earnings per share
0

Price Chart

CTLT Financial and Trading Overview

stock price 63.48
Previous Close 42.09
Open 42.12
Bid 31.5 x 900
Ask 51.23 x 800
Day's Range 42.05 - 43.95
52 Week Range 31.45 - 115.34
Volume 3.5M
Avg. Volume 4.79M
Market Cap 7.86B
Beta (5Y Monthly) 1.180985
PE Ratio (TTM) 181.625
EPS (TTM) 0
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 50

CTLT Valuation Measures

Enterprise Value 12.47B
Trailing P/E 181.625
Forward P/E 28.122581
PEG Ratio (5 yr expected) 8.02
Price/Sales (ttm) 1.7481772
Price/Book (mrq) 1.6683252
Enterprise Value/Revenue 2.773
Enterprise Value/EBITDA 14.666

Trading Information

Stock Price History

Beta (5Y Monthly) 1.180985
52-Week Change -57.47%
S&P500 52-Week Change 20.43%
52 Week High 115.34
52 Week Low 31.45
50-Day Moving Average 43.31
200-Day Moving Average 57.57

CTLT Share Statistics

Avg. Volume (3 month) 4.79M
Avg. Daily Volume (10-Days) 4.98M
Shares Outstanding 180.27M
Float 179.51M
Short Ratio 1.33
% Held by Insiders 0.36%
% Held by Institutions 105.82%
Shares Short 8.16M
Short % of Float 5.07%
Short % of Shares Outstanding 4.53%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin 0.48%
Operating Margin (ttm) 9.83%
Gross Margin 28.63%
EBITDA Margin 18.91%

Management Effectiveness

Return on Assets (ttm) 2.61%
Return on Equity (ttm) 0.47%

Income Statement

Revenue (ttm) 4.5B
Revenue Per Share (ttm) 25.11
Quarterly Revenue Growth (yoy) -18.50%
Gross Profit (ttm) 1.64B
EBITDA 850M
Net Income Avi to Common (ttm) 21M
Diluted EPS (ttm) 0.24
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 252M
Total Cash Per Share (mrq) 1.4
Total Debt (mrq) 4.86B
Total Debt/Equity (mrq) 103.34
Current Ratio (mrq) 1.841
Book Value Per Share (mrq) 26.128

Cash Flow Statement

Operating Cash Flow (ttm) 127M
Levered Free Cash Flow (ttm) -508000000

Profile of

Country United States
State NJ
City Somerset
Address 14 Schoolhouse Road
ZIP 08873
Phone 732 537 6200
Website https://www.catalent.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 19000

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics, and cell and gene therapies in clinical trials. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply services. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was incorporated in 2007 and is headquartered in Somerset, New Jersey.

Q&A For Stock

What is a current CTLT stock price?

CTLT stock price today per share is 63.48 .

How to purchase stock?

You can buy CTLT shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ?

The stock symbol or ticker of is CTLT.

Which industry does the company belong to?

The industry is Drug Manufacturers-Specialty & Generic.

How many shares does have in circulation?

The max supply of shares is 0.

What is Price to Earnings Ratio (PE Ratio)?

PE Ratio is 0.00000000 now.

What was earnings per share over the trailing 12 months (TTM)?

EPS is 0 over the trailing 12 months.

Which sector does the company belong to?

The sector is Healthcare.

CTLT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
S&P 500 (Yahoo.com) GSPC 5049.75 USD
-0.48
3.56B USD 4835.04 USD 5246.57 USD 3.56B USD
S&P 500 INDEX SPX 4994.23 USD
-1.57
3.41B USD 4835.04 USD 5246.57 USD 3.41B USD
Nasdaq US Smart Pharmaceuticals NQSSPH 1306.81 USD
-1.82
1267.2 USD 1347.29 USD
NYSE COMPOSITE (DJ) NYA 17220.16 USD
-2.26
16820.12 USD 18021.29 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1390.15 USD
<0.01
2100.38 AUD 1390.15 USD 2100.38 AUD 1390.15 USD

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap